benzidine has been researched along with curcumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, QF; Geng, H; Liang, ZF; Sun, X; Wang, Y; Xie, DD; Yu, DX; Zhang, ZQ; Zhao, L; Zhong, CY | 1 |
| Geng, H; Liu, J; Liu, Z; Ma, J; Yu, D; Zhang, Z; Zhao, L; Zhong, C | 1 |
2 other study(ies) available for benzidine and curcumin
| Article | Year |
|---|---|
Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells.
Topics: Antineoplastic Agents; Benzidines; Cell Culture Techniques; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Humans; MAP Kinase Signaling System; Urinary Bladder Neoplasms | 2016 |
Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
Topics: Antineoplastic Agents; Benzidines; Benzodiazepinones; Carcinogenesis; Cells, Cultured; Curcumin; Epithelial-Mesenchymal Transition; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 7; Protein Kinase Inhibitors; Protein Kinases; Transcription Factor AP-1; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2017 |